Zi-Yi Zhao (Ziyi Zhao)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 8

Top Topics

Signaling Pathway

Cancer Stem Cells

Rheumatoid Arthritis

Top Venues

Stem cells international

Disease markers

Journal of oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Yu-Chen Li, Yun Yuan, Luyao Yang, Hongqing Chen, Xufan Zhang, Tian Wen, Wenhao Liao, Maoyuan Zhao, Zi-Yi Zhao, Qiong-Ying Hu
AT7867 Inhibits the Growth of Colorectal Cancer Stem-Like Cells and Stemness by Regulating the Stem Cell Maintenance Factor Ascl2 and Akt Signaling. Stem cells international 2023 (2023)
Yu-Chen Li, Yun Yuan, Luyao Yang, Hongqing Chen, Xufan Zhang, Tian Wen, Wenhao Liao, Maoyuan Zhao, Zi-Yi Zhao, Qiong-Ying Hu
AT7867 Inhibits the Growth of Colorectal Cancer Stem-Like Cells and Stemness by Regulating the Stem Cell Maintenance Factor Ascl2 and Akt Signaling. Stem cells international 2023 (2023)
Ke Zhang, Jian Hu, Zi-Yi Zhao
Fumagillin regulates stemness and malignancies in cancer stem-like cells derived from liver cancer via targeting to MetAP-2. PloS one 18 (7) (2023)
Zhixing Chen, Hui Yang, Qianlu Zhang, Qiong-Ying Hu, Zi-Yi Zhao
Chelerythrine Inhibits Stemness of Cancer Stem-Like Cells of Osteosarcoma and PI3K/AKT/mTOR Signal. Journal of oncology 2022 (2022)
Cuiwei Zhang, Shuiqin Li, Zi-Yi Zhao
β -Elemene Promotes Apoptosis Induced by Hyperthermia via Inhibiting HSP70. Disease markers 2022 (2022)
Hong Liu, Changjin Chen, Jinhao Zeng, Zi-Yi Zhao, Qiongying Hu
MicroRNA-210-3p is transcriptionally upregulated by hypoxia induction and thus promoting EMT and chemoresistance in glioma cells. PloS one 16 (7) (2021)
Qiong-Ying Hu, Yun Yuan, Yu-Chen Li, Lu-Yao Yang, Xiang-Yu Zhou, Da-Qian Xiong, Zi-Yi Zhao
Programmed Cell Death Ligand 1-Transfected Mouse Bone Marrow Mesenchymal Stem Cells as Targeted Therapy for Rheumatoid Arthritis. BioMed research international 2021 (2021)
Chong Xiao, Xi Fu, Yuting Wang, Hong Liu, Yifang Jiang, Zi-Yi Zhao, Fengming You
Transferrin receptor regulates malignancies and the stemness of hepatocellular carcinoma-derived cancer stem-like cells by affecting iron accumulation. PloS one 15 (12) (2020)